PHIO filings
Corporate insider profile
Robert J Bitterman Filing Activity
Latest reported as Chairman, Pres. & CEO of Phio Pharmaceuticals Corp. (PHIO).
- Purchase filings
- 2
- Reported companies
- 1
- Net open-market value
- $20,500
- Latest transaction
- Aug 18, 2026
Affiliated corporations
Reported company relationships
Transaction history
